Creo Medical Group PLC (CMEOF)

OTCMKTS · Delayed Price · Currency is USD

0.1500

0.00 (0.00%)

At close: Sep 25, 2026

Market Cap	72.85M +9.8%
Revenue (ttm)	8.08M +50.0%
Net Income	7.13M
EPS	0.02
Shares Out	n/a
PE Ratio	10.21
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Open	0.1500
Previous Close	n/a
Day's Range	0.1500 - 0.1500
52-Week Range	0.1500 - 0.2256
Beta	0.91
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 1, 2026

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. It also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablati... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2003

Employees 104

Stock Exchange OTCMKTS

Ticker Symbol CMEOF

Financial Performance

Financial numbers in GBP Financial Statements